Variability of Botulinum Toxins: Challenges and Opportunities for the Future

Christine Rasetti-Escargueil (1, 2) , Emmanuel Lemichez (1, 2) , Michel R. Popoff (1, 2)

1 Toxines bactériennes - Bacterial Toxins
2 UPD7 - Université Paris Diderot - Paris 7

Botulinum neurotoxins (BoNTs) are the most potent known toxins, and are therefore classified as extremely harmful biological weapons. However, BoNTs are therapeutic drugs that are widely used and have an increasing number of applications. BoNTs show a high diversity and are divided into multiple types and subtypes. Better understanding of the activity at the molecular and clinical levels of the natural BoNT variants as well as the development of BoNT-based chimeric molecules opens the door to novel medical applications such as silencing the sensory neurons at targeted areas and dermal restoration. This short review is focused on BoNTs' variability and the opportunities or challenges posed for future clinical applications.

Keywords: BoNT variants; botulinum neurotoxins (BoNTs); subtypes

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Cellular Biology; Subcellular Processes [q-bio.SC]; Cell Behavior [q-bio.CB]

Christine Rasetti-Escargueil, Emmanuel Lemichez, Michel R. Popoff. Variability of Botulinum Toxins: Challenges and Opportunities for the Future. Toxins, 2018, 10 (9), pp.374. ⟨10.3390/toxins10090374⟩. ⟨pasteur-02453834⟩